Area of research
Oncology · Rheumatology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Rheumatoid Arthritis Research and Therapies, Colorectal Cancer Treatments and Studies, and Chronic Lymphocytic Leukemia Research.
Immune-related encephalitis after immune checkpoint inhibitor therapy
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases
Treatment of rheumatic adverse events of cancer immunotherapy
Experience with telemedicine amongst rheumatology clinicians during the COVID-19 pandemic: an international survey
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry
A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).
Checkpoint Inhibitor–Associated Arthritis
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis
Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy
2019 American College of Rheumatology Recommended Patient‐Reported Functional Status Assessment Measures in Rheumatoid Arthritis
Rheumatic immune-related adverse events from cancer immunotherapy
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen
Rheumatic and Musculoskeletal Immune‐Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology